Importance of lipid microdomains, rafts, in absorption, delivery, and biological effects of resveratrol

Annals of the New York Academy of Sciences

Volumn 1290, Issue 1, 2013, Pages 90-97

  Delmas, Dominique ^a,b   Aires, Virginie ^a,b   Colin, Didier J ^c   Limagne, Emeric ^a,b   Scagliarini, Alessandra ^a,b   Cotte, Alexia K ^a,b   Ghiringhelli, François ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Chu   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Apoptosis; Cancer; Rafts; Resveratrol; Transport

Indexed keywords

LIPID; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CELL STRAIN HEPG2; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENDOCYTOSIS; LIPID RAFT; NONHUMAN;

EID: 84880375521     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12177     Document Type: Article

References (46)

1. Langcake, P. & R. Pryce. 1977. A new class of phytoalexins from grapevines. Experentia. 33: 1151-1152.
2. Jang, M. et al. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
3. Delmas, D. et al. 2006. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr. Drug Targets 7: 423-442.
4. Colin, D. et al. 2009. Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells. Int. J. Cancer 124: 2780-2788.
5. Marel, A.K. et al. 2008. Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells. Mol. Nutr. Food Res. 52: 538-548.
6. Delmas, D., E. Solary & N. Latruffe. 2011. Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr. Med. Chem. 18: 1100-1121.
7. Lin, H.Y. et al. 2008. Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells. J. Cell Biochem. 104: 2131-2142.
8. Engelman, D.M. 2005. Membranes are more mosaic than fluid. Nature 438: 578-580.
9. Simons, K. & G. van Meer. 1988. Lipid sorting in epithelial cells. Biochemistry 27: 6197-6202.
10. Lancon, A. et al. 2004. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem. Biophys. Res. Commun. 316: 1132-1137.
11. Colin, D. et al. 2011. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. Cancer Prev. Res. (Phila) 4: 1095-1106.
12. Ikonen, E. 2001. Roles of lipid rafts in membrane transport. Curr. Opin. Cell Biol. 13: 470-477.
13. Nichols, B.J. & J. Lippincott-Schwartz. 2001. Endocytosis without clathrin coats. Trends Cell Biol. 11: 406-412.
14. Nichols, B.J. 2002. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat. Cell Biol. 4: 374-378.
15. Lamaze, C. et al. 2001. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell 7: 661-671.
16. van der Luit, A.H. et al. 2002. Alkyl-lysophospholipid accumulates in lipid rafts and induces apoptosis via raft-dependent endocytosis and inhibition of phosphatidylcholine synthesis. J. Biol. Chem. 277: 39541-39547.
17. Yang, H.L. et al. 2009. Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model. J. Transl. Med. 7: 22.
18. Lajoie, P. & I.R. Nabi. 2010. Lipid rafts, caveolae, and their endocytosis. Int. Rev. Cell Mol. Biol. 282: 135-163.
19. Lin, H.Y. et al. 2006. Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB J. 20: 1742-1744.
20. Bergh, J.J. et al. 2005. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146: 2864-2871.
21. Lin, H.Y. et al. 2008. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated. Carcinogenesis 29: 62-69.
22. Baillat, G. et al. 2008. Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells. Biochim. Biophys. Acta. 1783: 2323-2331.
23. Wary, K.K. et al. 1998. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94: 625-634.
24. Hsieh, T.C. et al. 2011. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3. Int. J. Cancer 129: 2732-2743.
25. Gajate, C. & F. Mollinedo. 2001. The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 98: 3860-3863.
26. Delmas, D. et al. 2003. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J. Biol. Chem. 278: 41482-41490.
27. Krammer, P.H. 1999. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71: 163-210.
28. Smith, C.A., T. Farrah & R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962.
29. Jiang, S. et al. 1999. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways. Hepatology 29: 101-110.
30. Clement, M.V. et al. 1998. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002.
31. Bernhard, D. et al. 2000. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 7: 834-842.
32. Dorrie, J. et al. 2001. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 61: 4731-4739.
33. Tinhofer, I. et al. 2001. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J. 15: 1613-1615.
34. Micheau, O. et al. 1999. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274: 7987-7992.
35. Hueber, A.O. et al. 2002. An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep. 3: 190-196.
36. Reis-Sobreiro, M., C. Gajate & F. Mollinedo. 2009. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene 28: 3221-3234.
37. Grassme, H. et al. 2001. CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276: 20589-20596.
38. Delmas, D. et al. 2004. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 23: 8979-8986.
39. Ghetie, M.A. et al. 2006. Rituximab but not other anti-CD20 antibodies reverses multidrug resistance in 2 B lymphoma cell lines, blocks the activity of P-glycoprotein (P-gp), and induces P-gp to translocate out of lipid rafts. J. Immunother. 29: 536-544.
40. Pohland, T. et al. 2006. Bax and Bak are the critical complementary effectors of colorectal cancer cell apoptosis by chemopreventive resveratrol. Anticancer Drugs 17: 471-478.
41. Belleri, M. et al. 2008. alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. Mol. Cancer Ther. 7: 3761-3770.
42. Desgrosellier, J.S. & D.A. Cheresh. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10: 9-22.
43. Brittes, J. et al. 2010. Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects. Chem. Phys. Lipids 163: 747-754.
44. Tsuchiya, H. et al. 2002. Membrane-rigidifying effects of anti-cancer dietary factors. Biofactors 16: 45-56.
45. Murphy, D.A. & S.A. Courtneidge. 2011. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat. Rev. Mol. Cell Biol. 12: 413-426.
46. Aires, V. et al. 2013. Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death. Mol. Nutr. Food Res. Mar 14. doi: 10.1002/mnfr.201200766. [Epub ahead of print].